Atlas Trials

PEARL Schizophrenia Maintenance

Clinical trial NCT01435928 · COMPLETED

Trial details

NCT number
NCT01435928
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-09-01
Primary completion
2013-08-01
Enrollment
676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.